RT Journal Article
SR Electronic
T1 Smoking cessation intervention in Australian general practice: a secondary analysis of a cluster randomised controlled trial
JF British Journal of General Practice
JO Br J Gen Pract
FD British Journal of General Practice
SP e458
OP e464
DO 10.3399/BJGP.2020.0906
VO 71
IS 707
A1 Rukshar K Gobarani
A1 Nicholas A Zwar
A1 Grant Russell
A1 Michael J Abramson
A1 Billie Bonevski
A1 Anne E Holland
A1 Eldho Paul
A1 Narelle S Cox
A1 Sally Wilson
A1 Johnson George
YR 2021
UL http://bjgp.org/content/71/707/e458.abstract
AB Background GPs have limited capacity to routinely provide smoking cessation support. New strategies are needed to reach all smokers within this setting.Aim To evaluate the effect of a pharmacist-coordinated interdisciplinary smoking cessation intervention delivered in Australian general practice.Design and setting Secondary analysis of a cluster randomised controlled trial (RCT) conducted in 41 Australian general practices.Method In all, 690 current smokers were included in this study: 373 from intervention clinics (n = 21) and 317 from control clinics (n = 18). A total of 166 current smokers had spirometry-confirmed chronic obstructive pulmonary disease (COPD). In the intervention clinics, trained pharmacists provided smoking cessation support plus Quitline referral. Control clinics provided usual care plus Quitline referral. Those with COPD in the intervention group (n = 84) were referred for home medicines review (HMR) and home-based pulmonary rehabilitation (HomeBase), which included further smoking cessation support. Outcomes included carbon monoxide (CO)-validated smoking abstinence, self-reported use of smoking cessation aids, and differences between groups in readiness-to-quit score at 6 months.Results Intention-to-treat analysis showed similar CO-validated abstinence rates at 6 months in the intervention (4.0%) and control clinics (3.5%). No differences were observed in readiness-to-quit scores between groups at 6 months. CO-validated abstinence rates were similar in those who completed HMR and at least six sessions of HomeBase to those with COPD in usual care.Conclusion A pharmacist-coordinated interdisciplinary smoking cessation intervention when integrated in a general practice setting had no advantages over usual care. Further research is needed to evaluate the effect of HMR and home-based pulmonary rehabilitation on smoking abstinence in smokers with COPD.